Clinical Trial Update: Modified CV Regimen in Optic Pathway Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a modified CV regimen for optic pathway glioma in pediatric patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Optic Nerve Glioma
• Optic Pathway Glioma

Snippet

Sponsor: Beijing Sanbo Brain Hospital | Conditions: Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma | Phase 2 | Status: RECRUITING